Phylogica signs Asthma research agreement

Subiaco-based drug development company Phylogica Ltd will allow the Swiss Institute of Allergy & Asthma Research to screen its libraries of proteins for potential vaccine leads under a research collaboration agreement, the company has announced.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byLedge Finance

Phylogica (PYC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

BNiQ Disclaimer